Beth Darnall

Meeting Report Published in Journal of Pain Research Explores Dental Pain Management and Opioid Prescribing During and Beyond COVID-19 Pandemic

Retrieved on: 
Monday, May 31, 2021

NEW YORK, May 31, 2021 /PRNewswire-PRWeb/ --A new meeting report published in the Journal of Pain Research explores pain management and opioid prescribing in dentistry during and beyond the COVID-19 Pandemic.

Key Points: 
  • NEW YORK, May 31, 2021 /PRNewswire-PRWeb/ --A new meeting report published in the Journal of Pain Research explores pain management and opioid prescribing in dentistry during and beyond the COVID-19 Pandemic.
  • Topics discussed include Precision Medicine for Orofacial Pain Management, Substance Risk Assessments in Dentistry, Opioid Moderatism and Opioid Sparing in Children and Adolescents.
  • To read the full meeting report please visit: https://www.dovepress.com/pain-management-for-dental-medicine-in-2021-op...
    The Journal of Pain Research is an international, peer-reviewed, open access, online journal that welcomes laboratory and clinical findings in the fields of pain research and the prevention and management of pain.
  • The Journal of Pain Research is the official journal of the American Society of Pain & Neuroscience.

AppliedVR Completes Pivotal Trial Finding Virtual Reality Is a Holistic Treatment for Chronic Pain

Retrieved on: 
Wednesday, February 24, 2021

AppliedVR , a pioneer advancing the next generation of digital medicine, today announced results from its pivotal randomized controlled trial (RCT), evaluating virtual reality (VR) therapy for treating chronic pain at home.

Key Points: 
  • AppliedVR , a pioneer advancing the next generation of digital medicine, today announced results from its pivotal randomized controlled trial (RCT), evaluating virtual reality (VR) therapy for treating chronic pain at home.
  • EaseVRx is an eight-week program delivered via a virtual reality medical device which teaches participants how to recognize and adjust cognitive, emotional, and physical responses to chronic pain using one session per day.
  • Already the most evidence-backed VR provider in healthcare, AppliedVR is engaged with multiple big-name insurers to evaluate its platform as a covered treatment for chronic pain.
  • AppliedVR is a leader in digital therapeutics, pioneering virtual reality-based treatments that address the complexity of chronic pain.

Study Highlights Acceptance of Pain Management App in Post-Surgical Patients

Retrieved on: 
Thursday, October 22, 2020

TORONTO, Oct. 22, 2020 /PRNewswire/ --Researchers of the University Health Network published a user engagement study of the pain management app , Manage My Pain, in Sage Journals' DIGITAL HEALTH.

Key Points: 
  • TORONTO, Oct. 22, 2020 /PRNewswire/ --Researchers of the University Health Network published a user engagement study of the pain management app , Manage My Pain, in Sage Journals' DIGITAL HEALTH.
  • They are provided with a multi-disciplinary approach to pain management to help prevent chronic post-surgical pain and long-term opioid use.
  • Manage My Pain is offered to all patients to self-manage their pain, record their progress, and communicate with their clinical team.
  • With its award-winning app, Manage My Pain, ManagingLife works with disability carriers, health plans, pain clinics, and clinical trials to help healthcare professionals better measure and manage their patients' pain and medications.

First Scientific Study Using Virtual Reality to Treat Chronic Pain at Home Finds AppliedVR Platform Feasible, Scalable and Effective

Retrieved on: 
Thursday, July 9, 2020

The study, which was published in JMIR-FR , found that a self-administered, skills-based VR treatment program was not only a feasible and scalable way to treat chronic pain, it also was effective at improving on multiple chronic pain outcomes.

Key Points: 
  • The study, which was published in JMIR-FR , found that a self-administered, skills-based VR treatment program was not only a feasible and scalable way to treat chronic pain, it also was effective at improving on multiple chronic pain outcomes.
  • Todays study sought to demonstrate the feasibility and efficacy of people using the AppliedVR program at home on themselves to manage their chronic pain.
  • People with chronic pain often have limited access to comprehensive pain care that includes skills-based behavioral medicine.
  • We tested whether VR that was self-administered at home would be an effective therapy for chronic pain, said Dr. Beth Darnall, AppliedVRs chief science advisor, who co-authored the study.

AppliedVR Partners with Red One Medical to Empower Caregivers on the Frontlines of the COVID-19 Fight by Providing Comprehensive Virtual Reality Stress Management Tools

Retrieved on: 
Monday, May 4, 2020

AppliedVR and Red One Medical look to offer therapeutic VR programs for pain and anxiety management for VA patients and staff.

Key Points: 
  • AppliedVR and Red One Medical look to offer therapeutic VR programs for pain and anxiety management for VA patients and staff.
  • "The COVID-19 crisis is taxing our most critical resource: frontline caregivers," says Dr. Beth Darnall, chief science advisor from AppliedVR.
  • Our solution can be quickly integrated and provide immediate relief," said Charles Pollak, CEO and Founder of Red One Medical.
  • Red One Medical identifies and delivers advanced medical and pharmaceutical technologies that transform care for America's military veterans.

AppliedVR Receives NIDA Grant to Study Virtual Reality as an Opioid-Sparing Tool for Pain

Retrieved on: 
Tuesday, October 22, 2019

The grants will enable the company to advance two clinical trial programs respectively with Geisinger and Cleveland Clinic , studying two of its virtual reality therapeutic platforms, RelieVRx and EaseVRx.

Key Points: 
  • The grants will enable the company to advance two clinical trial programs respectively with Geisinger and Cleveland Clinic , studying two of its virtual reality therapeutic platforms, RelieVRx and EaseVRx.
  • The NIDA funded trials will help inform the Company's regulatory pathway with the U.S. Food and Drug Administration (FDA).
  • "We are grateful to NIDA for its confidence in our vision and ability to execute a novel opioid-sparing treatment option," said Beth Darnall, Chief Science Advisor to AppliedVR.
  • Beyond advancing this novel intervention, this represents an important milestone in advancing therapeutic virtual reality as a new standard of care.